Expert Strategic Advisory and Fractional Leadership for BioPharma Commercialization
Executive-level consulting and fractional support for organizations shaping strategy, launch, and growth across specialty markets.
Strategic Leadership Empowering Biopharma Growth
Led by Kurt Harrington, MBA with 25+ years of experience, we specialize in bridging the gap between scientific innovation and commercial execution. We offer a personal, principal-led model that integrates directly into leadership teams to de-risk assets and navigate critical milestones.
Our model is built on personal, principal-led engagement, offering the depth of 25+ years of experience with the flexibility to scale specialized project teams as mandates require.
Drive Strategic Success and Market Leadership
Discover how our expert leadership and advisory services accelerate your biopharma innovation and commercial impact.
Fractional & Advisory
Supporting commercial teams and founders with senior-level strategy, execution, and decision support.
Integrated Commercial Strategy
Bringing clinical, medical, and commercial perspectives together to strengthen early-stage programs and accelerate growth for brands facing adoption or differentiation challenges.
Specialized Therapeutic Expertise
Offering deep knowledge in Immunology, Fibrosis, Neurology, Psychiatry and Cardio-Renal-Metabolic landscape to enhance decision-making and outcomes.
Strategic Leadership for Biopharma Growth
Harrington Life Science Consulting provides strategic advisory and fractional executive leadership to pharmaceutical and biotech companies. We specialize in bridging the gap between complex scientific innovation and commercial execution, offering direct, principal-level guidance to help teams navigate critical milestones.
Fractional Commercial Leadership
Delivering adaptable commercial leadership and strategic horsepower wherever teams need added capacity or expertise.
Commercial & Product Strategy
Directing cross-functional product development, TPP design, and indication prioritization to accelerate clinical relevance.
New Product Planning & Market Shaping
Harmonizing market opportunity, unmet need, and early development strategy to position assets for success.
Launch & In-Market Growth Strategy
Supporting teams from pre-launch planning through post-launch performance – readiness, refinement, and in-market optimization.
Proven Experience
Deep experience shaping strategy, execution, and optimizing market performance.
Strategic Growth
Driving meaningful progress at critical inflection points by aligning product strategy, market opportunity, and organizational focus – including >50% YoY brand growth .
Market Leadership
Extensive track record in launch planning and market development for key brands – including RITUXAN for rheumatoid arthritis, SEROQUEl as the global leading anti-psychotic, and BYETTA the first in class GLP-1.
Therapeutic Depth
Experience spanning immunology, fibrosis, cardio-renal-metabolic, neurology, and psychiatry, supported by deep work across hospital, specialty, and institutional channels that shape access and adoption.
PO Box 3323
Rancho Santa Fe, CA 92067